11.45am – 12.15pm BST, 10 June 2025 ‐ 30 mins
Plenary
11.45 Steroid metabolomics for personalised diagnosis and treatment - Wiebke ArltIan trained in Clinical Biochemistry in Dundee and Nottingham, then moved to NHS Lanarkshire initially as a Principal Biochemist, and was later appointed to a post as Consultant Clinical Scientist and Clinical Lead, where he developed an interest in laboratory processes and IT. He was the Clinical Lead for the Scottish Clinical Biochemistry Managed Diagnostic Network from 2016-2020. He moved into his current role as Consultant Clinical Scientist and Lead Clinician in Biochemistry at the QEUH in Glasgow in 2020.
Ian currently chairs the Specialist Advisory Committee for Clinical Biochemistry within the Royal College of Pathologists and after sitting on many committees of the Association for Laboratory Medicine, he was appointed as President Elect in 2024 and will take up the Presidency at LabMedUk in Manchester later this year.
Pronouns: He/him/his
Wiebke Arlt is the Director of the MRC Laboratory of Medical Sciences (LMS), one of two intramural research institute of the UK Medical Research Council. The LMS is located on the Imperial Hammersmith Campus in London and is dedicated to the investigation of mechanisms underlying cardiometabolic disease and ageing, with a special focus on sex differences.
At the LMS, Wiebke leads a multi-disciplinary research group that investigates steroid metabolism and action in health and disease, with a focus on the sex-specific role of androgens in metabolic dysfunction. Wiebke is also an honorary consultant endocrinologist at Imperial College Healthcare NHS Trust with a special interest in adrenal and reproductive disorders.
Wiebke's scientific work has attracted major national and international prizes. She was elected Fellow of the UK Academy of Medical Sciences in 2010.